Prana Biotechnology Ltd (NASDAQ:PRAN)

BATS BZX Real-Time Price
 -0.02 / -1.43%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Prana Biotechnology Ltd. is focused on the research and development of treatments for Alzheimer's, Huntington's disease and other major age related degenerative disorders. It is developed a proprietary library of class chemical compounds, which is combined with a drug development program to explore novel therapeutics in multiple disease indications. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Parkville, Australia.

Contact Information

Prana Biotechnology Ltd.
369 Royal Parade
Parkville Victoria (vic) 3052
P:(139) 349-4906
Investor Relations:



Other institutional1.84%
Mutual fund holders0.02%
Individual stakeholders--

Top Executives

Geoffrey Paul KemplerExecutive Chairman & Chief Executive Officer
Dianne AngusChief Operating Officer
Richard RevelinsChief Financial Officer & Secretary

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.